These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23882124)

  • 1. The role of HCA2 (GPR109A) in regulating macrophage function.
    Zandi-Nejad K; Takakura A; Jurewicz M; Chandraker AK; Offermanns S; Mount D; Abdi R
    FASEB J; 2013 Nov; 27(11):4366-74. PubMed ID: 23882124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.
    Feingold KR; Moser A; Shigenaga JK; Grunfeld C
    J Lipid Res; 2014 Dec; 55(12):2501-8. PubMed ID: 25320346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization.
    Shi Y; Lai X; Ye L; Chen K; Cao Z; Gong W; Jin L; Wang C; Liu M; Liao Y; Wang JM; Zhou N
    Sci Rep; 2017 Feb; 7():42279. PubMed ID: 28186140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.
    Benyó Z; Gille A; Kero J; Csiky M; Suchánková MC; Nüsing RM; Moers A; Pfeffer K; Offermanns S
    J Clin Invest; 2005 Dec; 115(12):3634-40. PubMed ID: 16322797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages.
    Rahman M; Muhammad S; Khan MA; Chen H; Ridder DA; Müller-Fielitz H; Pokorná B; Vollbrandt T; Stölting I; Nadrowitz R; Okun JG; Offermanns S; Schwaninger M
    Nat Commun; 2014 May; 5():3944. PubMed ID: 24845831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models.
    He D; Fu S; Ye B; Wang H; He Y; Li Z; Li J; Gao X; Liu D
    J Neuroinflammation; 2023 Mar; 20(1):86. PubMed ID: 36991440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niacin activates the PI3K/Akt cascade via PKC- and EGFR-transactivation-dependent pathways through hydroxyl-carboxylic acid receptor 2.
    Sun H; Li G; Zhang W; Zhou Q; Yu Y; Shi Y; Offermanns S; Lu J; Zhou N
    PLoS One; 2014; 9(11):e112310. PubMed ID: 25375133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the niacin receptor HCA
    Yang R; He J; Wang Y
    Eur J Pharmacol; 2016 Nov; 791():124-136. PubMed ID: 27568840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niacin Ameliorates Neuro-Inflammation in Parkinson's Disease via GPR109A.
    Giri B; Belanger K; Seamon M; Bradley E; Purohit S; Chong R; Morgan JC; Baban B; Wakade C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of inflammatory mediator secretion by (-)-DHMEQ in mouse bone marrow-derived macrophages.
    Suzuki E; Sugiyama C; Umezawa K
    Biomed Pharmacother; 2009 Jun; 63(5):351-8. PubMed ID: 18635336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin attenuates the production of pro-inflammatory cytokines in LPS-induced mouse alveolar macrophages by HCA2 dependent mechanisms.
    Zhou E; Li Y; Yao M; Wei Z; Fu Y; Yang Z
    Int Immunopharmacol; 2014 Nov; 23(1):121-6. PubMed ID: 25038318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid.
    Pike NB
    J Clin Invest; 2005 Dec; 115(12):3400-3. PubMed ID: 16322787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.
    Lukasova M; Malaval C; Gille A; Kero J; Offermanns S
    J Clin Invest; 2011 Mar; 121(3):1163-73. PubMed ID: 21317532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Metformin on the Expression of GPR109A, NF-κB and IL-1β in Peripheral Blood Leukocytes from Patients with Type 2 Diabetes Mellitus.
    Xu X; Lin S; Chen Y; Li X; Ma S; Fu Y; Wei C; Wang C; Xu W
    Ann Clin Lab Sci; 2017 Sep; 47(5):556-562. PubMed ID: 29066482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxycarboxylic Acid Receptor Ligands Modulate Proinflammatory Cytokine Expression in Human Macrophages and Adipocytes without Affecting Adipose Differentiation.
    Mandrika I; Tilgase A; Petrovska R; Klovins J
    Biol Pharm Bull; 2018; 41(10):1574-1580. PubMed ID: 30270326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor.
    Qureshi AA; Guan XQ; Reis JC; Papasian CJ; Jabre S; Morrison DC; Qureshi N
    Lipids Health Dis; 2012 Jul; 11():76. PubMed ID: 22698256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways.
    Liu L; Guo H; Song A; Huang J; Zhang Y; Jin S; Li S; Zhang L; Yang C; Yang P
    BMC Immunol; 2020 Jun; 21(1):32. PubMed ID: 32503416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic Acid Receptor GPR109A Exerts Anti-Inflammatory Effects Through Inhibiting the Akt/mTOR Signaling Pathway in MIN6 Pancreatic β cells.
    Li Z; Li X; Lin S; Chen Y; Ma S; Fu Y; Wei C; Xu W
    Ann Clin Lab Sci; 2017 Nov; 47(6):729-737. PubMed ID: 29263047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,5-Dihydroxybenzoic acid, a specific agonist for hydroxycarboxylic acid 1, inhibits lipolysis in adipocytes.
    Liu C; Kuei C; Zhu J; Yu J; Zhang L; Shih A; Mirzadegan T; Shelton J; Sutton S; Connelly MA; Lee G; Carruthers N; Wu J; Lovenberg TW
    J Pharmacol Exp Ther; 2012 Jun; 341(3):794-801. PubMed ID: 22434674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy.
    Gambhir D; Ananth S; Veeranan-Karmegam R; Elangovan S; Hester S; Jennings E; Offermanns S; Nussbaum JJ; Smith SB; Thangaraju M; Ganapathy V; Martin PM
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2208-17. PubMed ID: 22427566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.